Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Healios KK Ord Shs HLOSF

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.


PINL:HLOSF - Post by User

Post by ama21968on Oct 04, 2010 8:21pm
213 Views
Post# 17527635

Halo says ... (NEW PRESENTATION)

Halo says ... (NEW PRESENTATION)

2011 - 2012 Production scenario:

HudBay Cold-Lost operation to generate cash flow

2010 - 2012 Exploration in vicinity of known surface deposits within 4-km radius to test feasibility of multiple open pit operations feeding a central mill facility

2011 - 2013 Regional exploration to discover additional near surface deposits

-------------------------------------------------------------------

Common Shares-Issued 18 million

 Warrants & Options ~2 million*

Market Capitalization $ 5.5 million

Working Capital $ 0.5 million

Ownership

Institutional 40%

Management and Insiders 5%

Retail 55%

-------------------------------------------------------------------
HudBay currently drilling to advance metallurgical testing

Decision to proceed to engineering expected January 2011

HudBay required to spend $1.35 million and pay $450,000 to earn 51% of 1.1 sq. km.

HudBay can earn 60% by paying additional $2 million before December 2011

HudBay can earn additional 7.5% by paying $2.5 million prior to production

Total of up to $6.3 million expenditure

Halo’s portion of estimated $3 million capital costs paid out from revenue

HudBay’s current work program - 100% more

than their required 2010 spending

------------------------------------------------------------------

Okay, I CAN WAIT..

Capitalization

<< Previous
Bullboard Posts
Next >>